Literature DB >> 11094125

Topiramate relieves refractory trigeminal neuralgia in MS patients.

M Zvartau-Hind1, M U Din, A Gilani, R P Lisak, O A Khan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094125     DOI: 10.1212/wnl.55.10.1587

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  21 in total

Review 1.  New antiepileptic drugs.

Authors:  C W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis.

Authors:  Qiang-Ping Wang; Min Bai
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

3.  Current pharmacologic approaches to treating neuropathic pain.

Authors:  To-Nhu H Vu
Journal:  Curr Pain Headache Rep       Date:  2004-02

4.  Topiramate therapy for symptomatic trigeminal neuralgia.

Authors:  A Siniscalchi; L Gallelli; D Scornaienghi; F Mancuso; G De Sarro
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

5.  Paroxysmal hemicrania responding to topiramate.

Authors:  A S Cohen; P J Goadsby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 6.  Diagnostic evaluation and treatment of trigeminal neuralgia.

Authors:  Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2009-08

7.  Paroxysmal hemicrania responding to topiramate.

Authors:  A S Cohen; P J Goadsby
Journal:  BMJ Case Rep       Date:  2009-07-07

Review 8.  Topiramate in the treatment of cluster headache.

Authors:  Brian E McGeeney
Journal:  Curr Pain Headache Rep       Date:  2003-04

Review 9.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

10.  Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosis.

Authors:  Antonio Siniscalchi; Luca Gallelli; Giovambattista De Sarro
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.